Event Information:
Dates:
September 11th to 15th, 2024
Location
Chicago, United States
Related Models
Humanized Liver Mouse, Infectious Disease Mouse Models (HIV, HBV)
TransCure BioServices at the 2024 International HBV Meeting: Advancing HBV Research Together
TransCure BioServices is thrilled to announce our participation in the 2024 International HBV Meeting, taking place from September 11 to 15, 2024, in Chicago, USA.
This influential conference is expected to gather experts and participants from around the world to discuss the latest advancements in HBV research. The event will feature cutting-edge studies, the development of new technologies and analytical methods, and joint discussions on therapeutic developments with patients and clinicians.
Join Ha-Yeon Kim-Penard, PhD, Scientist Business Developer, at the HBV Meeting 2024 to discover our latest advancements in humanized mice preclinical research models. Our innovative Humanized Liver mouse models play a crucial role in understanding HBV pathogenesis and developing new treatments. Ha-Yeon will also be presenting a scientific poster, showcasing our groundbreaking research. She is eager to discuss potential collaborations and explore how our cutting-edge solutions can support ongoing and future HBV research projects.
The HBV Meeting 2024 provides a powerful platform for networking with the HBV community.
This conference is a must-attend event for anyone involved in HBV research and treatment. It offers an unparalleled chance to expand your knowledge, present your latest research, and connect with global peers.
We look forward to welcoming you to Chicago and advancing HBV research together.
See you at the 2024 International HBV Meeting!
Attending in person for TransCure bioServices:
Ha-Yeon Kim-Penard, PhD, Business Development
Ha-Yeon Kim-Penard holds a PhD in Cell and Molecular Biology from the University of Paris, in France. She worked at the Curie Institute (Orsay, France) in the field of cancer biology in cutaneous melanoma, before joining the TransCure bioServices Team as Project Leader in 2020. She has led many in vivo preclinical projects encompassing immuno-oncology, infectious diseases, inflammatory diseases in humanized Immune System and humanized liver mouse models.